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Abstract
Background: A sufficient amount of bone is essential to ensure long-term stability of dental implants. To support
the bone regeneration process, different techniques and materials are available. It has been questioned whether
these techniques and materials may compromise implant survival compared to pristine bone. To properly answer
this question, long-term stability up to 20.2 years after insertion of implants placed in augmented or non-augmented
sites was retrospectively analysed.
Methods: Retrospective analysis included 10,158 implants from 3095 patients in three private practices who
underwent implant therapy with or without bone augmentation procedures. Different graft materials and
membranes were used for augmentation. If necessary, the graft was stabilised using a titanium mesh. Implant
survival was evaluated analysing explantation rates and Kaplan-Meier survival curves in augmented or non-
augmented sites. In additional subgroup analyses, augmentation procedures, graft materials and membranes
were compared applying descriptive statistics.
Results: The observation period varied from the day of implantation up to 20.2 years after implant insertion.
The overall implant survival was 95.5% (augmented sites 96.33%; native sites 94.27%). Comparison of Kaplan-Meier
survival curves revealed significantly better survival of implants in augmented sites (p = 0.0025). When comparing
different augmentation procedures, the best results were found for bone condensing followed by lateral
augmentation. Graft materials were used in 58.2%, membranes in 36.6% of all implant sites. The most often used
graft materials were a deproteinized bovine bone mineral (53.0%) and autogenous bone particles (32.5%). Both
provided the best results and showed a significantly better implant survival compared to no graft material using
the Kaplan-Meier method (p = 0.0104 and p < 0.0001). A native collagen membrane was used most often (74.0%
of the membrane sites) and provided the best results regarding implant survival in the log-rank test.
Conclusions: The retrospective analysis shows that implants inserted in augmented or native bone demonstrate
similar implant survival under the conditions of private practice compared to prospective studies. To establish a
broad base of support, further well-designed clinical trials are necessary.
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Background
Replacing missing teeth with dental implants is a routine
treatment in many dental practices. In order to achieve
adequate functional and aesthetic results, an optimal
three-dimensional implant position has to be assured
[1]. Various materials are available to build up missing
bone. While autogenous bone is usually regarded to be
the gold standard, harvesting may be associated with
morbidity and considerable post-operative resorption of
the augmented volume [2]. Therefore, bone substitutes
are often used either alone or in combination with au-
togenous bone. Among bone substitutes, deproteinized
bovine bone mineral has proven effectiveness in various
indications as shown in clinical studies [3–7]. The long-
term stability of the augmented volume found with this
material is probably due to its slow resorption rate [8].
In guided bone regeneration procedures, membranes
are often used to cover the graft and prevent ingrowth
of soft tissue [9]. Native collagen membranes have been
shown to allow bone formation with a low complication
rate [6, 10–12].
Questions have been raised whether implant survival
may be compromised in augmented sites since graft ma-
terials might impede and delay bone remodelling. While
some studies reported reduced survival for implants in
grafted areas [13, 14], other authors did not report any
significant differences of implant survival or implant
success between augmented and pristine bone [15, 16].
For sinus floor augmentation, Aghaloo et al. even found
favourable implant survival rates in augmented bone
[17].
Therefore, the objective of this study was to retro-
spectively analyse all consecutively placed implants in
patients fulfilling the inclusion criteria and complete pa-
tient data files within 20 years in three private practices
in terms of implant survival in augmented and non-
augmented sites. Secondary objectives were to evaluate
whether certain augmentation procedures or materials
may be advantageous in terms of implant survival.
Methods
The retrospective analysis evaluates patients who under-
went implant therapy with or without accompanying
augmentation procedures between August 1991 and
December 2011 in three private practices. Strengthening
the Reporting of Observational Studies in Epidemiology
(STROBE) guidelines were followed. To investigate the
effect of the different techniques applied on implant sur-
vival without overlapping impact of contraindications,
the following exclusion criteria were applied: patients
with uncontrolled diabetes mellitus, severe cardiovascu-
lar diseases (e.g. severe heart insufficiency), organ
transplants, intake of bisphosphates and smoking of
≥20 cigarettes/day. Only patients with complete data
regarding implantation procedure and implant survival
were included. During this time period, a total of
10,165 implants were inserted either with or without
augmentation. Seven implants were excluded from the
evaluation because the date of implantation was not
documented. Thus, 10,158 implants in 3095 consecu-
tively treated patients were included in the retrospect-
ive analysis. Of these patients, 1693 (54.7%, 5626
implants) were female, 1401 (45.3%, 4539 implants)
were male. For one patient, the sex was not docu-
mented. Mean age at the time of the implantation was
52.4 years (14.8 to 89.5). There was no difference re-
garding age or distribution of sex between patients with
or without augmentation. On average, female patients
received 3.32 and male patients 3.24 implants per
patient.
Surgeries as well as pre- and postsurgical care were
performed according to the standard procedures used in
the three centres. Implants were inserted according to
the manufacturers’ instructions. Patients were scheduled
3 months post-implantation followed by yearly control
visits after the completion of the implant-supported re-
storative therapy.
The following graft materials were used: autogenous bone
blocks, autogenous bone particles, Geistlich Bio-Oss (gran-
ules or collagen block, Geistlich Pharma AG, Wolhusen,
Switzerland), Cerasorb (Curasan, Kleinostheim, Germany),
Bioresorb (Implant Direct, Zurich, Switzerland),
Bonitmatrix (DOT, Rostock, Germany), Biovin Bovine
Bone (OT Medical, Bremen, Germany), Nanobone
(Artoss, Rostock, Germany), Osteograf (Dentsply
Tulsa Dental Specialities, Oklahoma, USA), Biogran
(Biomet 3i, Munich, Germany), Easygraft (Degradable
Solutions, Zurich, Switzerland), Endobone (Biomet 3i
Deutschland GmbH, Munich, Germany), Pepgen P15
(Dentsply Tulsa Dental Specialities, Oklahoma, USA),
Bioseed Oral Bone (Biotissue AG, Freiburg, Germany),
Ostim (Heraeus Kulzer, Hanau, Germany), Perioglass
(Novabone, Jacksonville, FL, USA) and Rebone
(Schütz Dental GmbH, Rosbach, Germany). Autogen-
ous bone was harvested during drilling and from the
chin, tibial plateau, iliac crest, maxillary tuberosity and
retromolar space.
The membranes applied included the native collagen
membrane Geistlich Bio-Gide (Geistlich Pharma AG,
Wolhusen, Switzerland) either alone or combined with
one of the following membranes: Vicryl (Johnson &
Johnson Medical GmbH, Norderstedt, Germany), Biovin
Membran (OT Medical, Bremen, Germany), Parasorb
Vlies (Resorba, Nuremberg, Germany), Gore-Tex Resolut
(W.L. Gore & Associates, Flagstaff, USA), Kollagenresorb
(RESORBA Medical GmbH, Nuremberg, Germany), Epi-
Guide (DSM, Exton, USA), Gore Resolut Adapt Regenera-
tive Membrane (W.L. Gore & Associates, Flagstaff, USA),
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Osseoguard (Biomet 3i, Munich, Germany), Ossix (Tel
Aviv, Israel), Parasorb Resodont (RESORBA Medical
GmbH, Nuremberg, Germany), Tefgen (Lifecore Biomed-
ical, Chaska, USA), Tutodent (Tutogen, Neunkirchen,
Germany), non-resorbable Gore-Tex membrane (GT,
W.L. Gore & Associates, Flagstaff, USA), Osseoquest
(W.L. Gore & Associates, Flagstaff, USA) and Inion GTR
(Curasan, Kleinostheim, Germany). If a titanium mesh
was used (Tiomesh, Dentaurum, Germany), the mem-
branes were placed over the mesh.
Patient data files were analysed regarding personal pa-
tient information, implantation process and implantation
outcome in terms of implant loss. Patient data included
information about the sex, date of birth, the number and
position of implants placed as well as the date of im-
plantation and explantation or last control visit. Regard-
ing the implantation procedure, the use of graft
materials and membranes were documented.
Collected data were retrospectively analysed in terms
of explantation rates to evaluate the survival between
implants undergoing augmentation or not. Additional
subgroup analysis included comparisons of different aug-
mentation procedures, graft materials and membranes.
In order to compare augmentation procedures, they
were categorised into lateral augmentation, three-
dimensional augmentation using a titanium mesh, bone
splitting/bone spreading, use of autogenous bone blocks,
internal sinus floor augmentation using the Osteotome
technique and external sinus floor augmentation using a
lateral window approach (one- and two-step procedure),
bone condensing or combinations of these procedures.
Bone splitting/spreading and bone condensing describe
accompanying augmentation procedures to equalise the
bone level with neighbouring sites.
Statistical evaluation
The statistical analysis was performed using SPSS 11.0.0
(IBM, Armonk, NY, USA) as well as SAS Version 9.2
(SAS Institute Inc., Cary, NC, USA). Metric parameters
were descriptively analysed for arithmetic mean and
standard deviation. To test the hypothesis of “no differ-
ences between augmented sites and non-augmented sites
in regard to survived implants”, survival of implants was
compared based on Kaplan-Meier survival curves using
log-rank test and included patient data up to a 20.2-year
observation period [18]. Subgroups were exploratory
analysed for statistical differences using log rank. A p
value of 0.05 was regarded to be significant.
Results
Of the 10,158 implants, 58.2% (5916 implants) were
inserted using an augmentation procedure. The minimal
observation period until the last control visit or until ex-
plantation was 0 days (day of implantation); the
maximum period was 20.2 years. Distribution of ana-
lysed implants according to the period of observation is
shown in Table 1.
A total of 4.53% (460 implants) of all implants were
lost during the observation period of 20.2 years. Analysis
of early and late implant loss revealed that 16 implants
(0.38%) without and 19 implants (0.32%) with augmen-
tation were extracted before connection to the supras-
tructure, whereas 227 implants (5.35%) without and
198 implants (3.35%) with augmentation were lost after
the attachment of the suprastructure within a 20.2-year
observational period. Statistical analysis using Kaplan-
Meier method and log-rank test revealed significantly
better (p = 0.0025) survival curves for implants inserted
with augmentation (96.33% of functional implants)
compared to implants without augmentation (94.27% of
functional implants) (Table 2 and Fig. 1). This was also
true if only single-crown implants were evaluated,
where the proportion of surviving implants was 98.84%
(23 explantations of 1980 implants) with augmentation
and 97.01% (34 explantations of 1136 implants) without
augmentation (p = 0.0028).
Table 1 Distribution of implants according to the period of
observation
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Augmentation procedures
The augmentation procedures performed most fre-
quently were lateral ridge augmentation and external
one-step sinus floor augmentation (Table 3). During the
observation period of 20.2 years, the percentage of sur-
viving implants ranged between 95.0 and 98.5% and
therefore slightly exceeded the one of no augmentation
(Table 3). However, in pairwise comparisons, significant
differences vs. no augmentation were only found for
lateral augmentation as well as for external and internal
sinus floor augmentations. In 57 implants, sinus lift was
combined with other augmentation procedures. The ab-
solute implant survival rate was 94.74% in these sites (p
= 0.8826 vs. no augmentation). Kaplan-Meier implant
survival curves are shown in Fig. 2.
When looking into the Kaplan-Meier implant survival
curves of the augmentation procedures using the log-
rank test, the highest implant survival was found for
bone condensing followed by lateral augmentation, in-
ternal sinus lift, transplantation of bone blocks, bone
splitting/spreading, titanium mesh, external sinus lift
(one- and two-step) and finally, no augmentation. This
sequence was statistically significant (p = 0.0336).
Membranes
In 36.6% of all implant sites, a membrane was used. In
74.0% of these sites, the native collagen membrane Geis-
tlich Bio-Gide was applied. Other often used membranes
were Geistlich Bio-Gide combined with other mem-
branes (7.38%), the non-resorbable Gore-Tex membrane
(6.19%) and Vicryl (6.03%).
In pairwise comparisons vs. no membrane, signifi-
cantly increased rates of implant loss were found for
Kollagen Vlies and Resodont, although the sample sizes
were quite small (Table 4). When evaluating the Kaplan-
Meier implant survival curves for the membranes (Fig. 3)
using the log-rank test, the following sequence for im-
plant survival was found (p = 0.0009): Geistlich Bio-Gide
(highest survival), Gore-Tex, Tefgen, Ossix, Biovin, Osso-
guard, Epigude, Inion, Geistlich Bio-Gide in combination
with other membranes, Vicryl, Resodont, Kollagen Vlies,
Tutodent, and no membrane (lowest survival).
Graft materials
The graft materials used most often were the deprotei-
nized bovine bone mineral, Geistlich Bio-Oss (53.0%)
and autogenous bone particles (32.5%). The use of both
graft materials resulted in higher absolute implant sur-
vival assessing the data to no graft material (p = 0.0104
and p < 0.0001). In contrast, Cerasorb showed lower im-
plant survival compared to no graft material (p =
0.0002). For the other materials, no differences were
found (Table 5).
When comparing the Kaplan-Meier implant survival
curves of the grafts (Fig. 4) to each other using the log-
Table 2 Implant loss in augmented and non-augmented sites up to 20.2 years after implant insertion
Augmentation Implants (n) Lost implants % (n) Early implant loss % (n) Late implant loss % (n) Absolute survival rate %
No augmentation 4242 5.73 (243) 0.38 (16) 5.35 (227) 94.27
With augmentation 5916 3.67 (217) 0.32 (19) 3.35 (198) 96.33
Total 10158 4.53 (460) 0.34 (35) 4.18 (425) 95.47




Fig. 1 a Kaplan-Meier survival curves for implants with or without
augmentation. Dashed line 95% confidence interval. b Kaplan-Meier
survival curves for single crown implants overall and with or without
augmentation. Dashed line 95% confidence interval
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rank test, the following sequence for implant survival
was found (p = 0.0001): Geistlich Bio-Oss (highest sur-
vival), other bone substitutes, autogenous bone particles,
Geistlich Bio-Oss + Cerasorb, Bioresorb, Cerasorb and
no graft material (lowest survival).
Discussion
The retrospective analysis presented here evaluates im-
plants inserted in three different private practices with or
without augmentation procedures. Treatments were per-
formed according to the standard protocols applied in the
private practices. More than 10,000 implants were inserted
in various indications and were followed up to 20.2 years
from the day of implant insertion. The overall implant sur-
vival rate was 95.5%. When only single-crown implants
were evaluated, the absolute survival rate increased to
98.8%. Various reviews have reported about the implant
survival similar to the results found here [15, 17, 19].
Table 3 Explantations of implants inserted using different augmentation procedures up to 20.2 years after implantation
Augmentation procedure Implants
(n)
Lost implants % (n) Absolute survival rate % p value
No augmentation 4242 5.72 (243) 94.28
Lateral augmentation 3210 4.02 (129) 95.98 0.0010
External sinus lift one-step 1101 4.09 (45) 95.91 0.0324
Bone condensing 422 1.90 (8) 98.1 0.0009
Bone splitting/bone spreading 374 3.74 (14) 96.26 0.2998
Internal sinus lift 314 2.55 (8) 97.45 0.0174
Autogenous bone block transplantation 241 3.32 (8) 96.68 0.1146
External sinus lift two-step 130 1.54 (2) 98.46 0.0410
Three-dimensional augmentation using Ti-mesh 124 2.42 (3) 97.58 0.1159




Fig. 2 Kaplan-Meier implant survival curves for augmentation procedures
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In our analysis, survival of the 10,158 implants ana-
lysed was slightly but significantly higher in augmented
bone than in pristine bone (96.3 vs. 94.3%). This might
result from an increased mineral density, as usually ob-
served after augmentation, and the concomitant higher
bone-to-implant contact [20]. High number of implants
analysed here allowed suited statistical analysis despite
of patient- and implant-specific variations. According to
the statistical results of survival curves, the hypothesis of
no difference might be withdrawn in favour for aug-
mented bone indicating a statistically significant positive
effect of grafting on implant survival. However, small
difference in absolute numbers should be carefully eval-
uated for clinical relevance. Previously, published studies
regarding implant survival between augmented and non-
augmented sites are inconclusive. In one retrospective
analysis which included 12,737 implants in 4206 pa-
tients, 59.7% of the implants were inserted using bone
augmentation or bone expanding procedures [16]. The
authors did not find a significant difference between the
Kaplan-Meier cumulative survival rates among grafted
and non-grafted sites. In a recent review which included
108 articles of all evidence levels, Jensen and Terheyden
found a high level of evidence that survival rates of
implants in augmented bone are very similar to the ones
of implants in pristine bone [15]. In another review,
Aghaloo et al. reported similar or even better results for
implants in augmented sites [17]. However, there are
also a few clinical studies in which reduced survival rates
for implants inserted in grafted areas were found [13,











No membrane 6439 0.0/20.2 4.77 (307) 95.23
Geistlich Bio-Gide 2743 0.0/16.2 3.76 (103) 96.24 0.4462
Geistlich Bio-Gide combined with other
membranes
279 0.0/10.2 3.23 (9) 96.77 0.7809
Gore-Tex 230 0.4/18.5 5.65 (13) 94.35 0.1671
Vicryl 224 0.0/18.4 6.70 (15) 93.3 0.6808
Tefgen 81 0.2/16 2.47 (2) 97.53 0.1638
BioVin M 65 0/1.9 1.54 (1) 98.46 0.7816
Tutodent 49 0.1/5.9 8.16 (4) 91.84 0.0555
Resodont 21 0.1/3.6 14.29 (3) 85.71 0.0021
Kollagen Vlies 10 0.1/9.7 30.0 (3) 70 0.0006
Ossix 8 8.0/8.9 0.00 (0) 100 0.4781
Osseoguard 4 2.3/3.2 0.00 (0) 100 0.7061
Curasan InionGTR 3 1.0/1.0 0.00 (0) 100 0.7694
Epigide 2 4.9/4.9 0.00 (0) 100 0.7680
Total 10158 0.0/20.2 4.53 (460) 95.47
Metric parameters were calculated using descriptive statistics. P values for pairwise comparison vs. no membrane were calculated in accordance to Kaplan and
Meier using log-rank test
a
b
Fig. 3 Kaplan-Meier survival curves for membrane types
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14]. Differences in numbers of implants analysed, surgi-
cal techniques, indications and/or graft materials may
account for these inconsistent results and further studies
might be needed.
In the retrospective analysis shown here, the compari-
son of different augmentation procedures using the log-
rank test revealed the highest implant survival for bone
condensing followed by lateral ridge augmentation. The
lowest rankings were found for sinus floor augmentation
and no augmentation. In pairwise comparisons of
Kaplan-Meier implant survival curves to non-augmented
sites, a significantly higher implant survival was found
for lateral bone augmentation and sinus floor elevation.
However, all procedures provided a high implant sur-
vival of more than 94%. This indicates that under daily
practice all these augmentation procedures may provide
clinically acceptable results. Recent reviews have also re-
ported a high implant survival of more than 90% for
sinus augmentation [5, 15, 17, 21–23], lateral ridge aug-
mentation [15, 19, 24, 25], for bone splitting [21, 26] as
well as for three-dimensional augmentations using ti-
tanium mesh [27]. When augmentation procedures
were compared to each other, the authors were not
able to draw a clear conclusion on the superiority of a
certain augmentation procedure or grafting protocol
[15, 17, 21, 28].
In our analysis, membranes were used in 36.6% of the
implant sites. Small defects were treated with either a
bone substitute or bone particles without an additional
membrane. The membrane which was used in almost
75% of the cases was a native collagen membrane. Vari-
ous other studies have reported successful results using
this membrane in bone augmentation [6, 10–12] as well
as a low complication rate [29, 30]. Although in our ana-
lysis, the membrane was associated with a high absolute
survival rate of 96.24% and the best result in the log-
Table 5 Implants lost and in function up to 20.2 years after implant insertion using different graft materials
Graft material Implants (n) Min/max observation time (years) Lost implants % (n) Absolute survival rate % p value
No graft material 4609 0.0/20.2 5.51 (254) 94.49
Geistlich Bio-Oss 2939 0.0/15.6 2.76 (81) 97.24 0.0004
Autogenous bone particles 1801 0.0/17.8 3.94 (71) 96.06 0.1807
Cerasorb 284 0.0/12.6 10.56 (30) 89.44 0.0007
Bioresorb 145 0.1/11.6 6.90 (10) 93.10 0.7782
Bio-Oss + Cerasorb 105 0.0/5.8 2.86 (3) 97.14 0.6714
Other bone substitutes 275 0.0/18.6 4.00 (11) 96 0.1354
Total 10158 0.0/20.2 4.53 (460) 95.47
Metric parameters were calculated applying descriptive statistics. P values for pairwise comparison vs. no graft material were calculated in accordance to Kaplan
and Meier using log-rank test.
Fig. 4 Kaplan-Meier implant survival curves for bone and bone substitutes
Knöfler et al. International Journal of Implant Dentistry  (2016) 2:25 Page 7 of 10
rank test, it is still not possible to draw clear conclusions
on the superiority of any membrane, when implant sur-
vival is the only parameter under consideration.
The most often used graft material in our evaluation
was Geistlich Bio-Oss (53.0%) followed by autogenous
bone (32.5%). When compared to no graft, the use of
both grafts resulted in significantly higher implant sur-
vival rates. In various studies, the bone substitute was
found to promote bone regeneration and to allow for
long-term stability of the augmented volume [3, 5–8,
31–33]. A recent meta-analysis compared Geistlich Bio-
Oss and autogenous bone [24]: For maxillary sinus
floor augmentation, a mean implant survival rate of
98.6 ± 2.6% was found for bone substitute, 88.6 ±
4.1% for autogenous bone + bone substitute and
97.4 ± 2.2% for autogenous bone alone. While there
was a trend in favour of Geistlich Bio-Oss, the dif-
ferences were not statistically significant. When the
authors evaluated the studies with vertical and/or
lateral alveolar ridge augmentation, they found simi-
lar mean implant survival rates for the three treat-
ment modalities (97.4 ± 2.5% for Geistlich Bio-Oss,
100 ± 0.0% for autogenous bone + Geistlich Bio-Oss,
98.6 ± 2.9% for autogenous bone alone). Data is
based on 4687 implants in 1816 patients. This find-
ing is in line with the results from our study. In
contrast to Geistlich Bio-Oss, the use of a synthetic
material (Cerasorb) resulted in a significantly lower
implant survival than no graft in the pairwise com-
parison, although in the log-rank test, the synthetic
material demonstrated better results than no graft
material used. However, the heterogeneity of the data
does not allow drawing statistical conclusions on the
superiority between those bone substitutes that were
used rather rarely.
The retrospective analysis presented here included a
large number of implants followed up to 20.2 years.
While it allows conclusions on the efficacy of augmenta-
tion procedures in daily practice, there are some limita-
tions. It was not possible to evaluate the initial defect
size and morphology. Therefore, it is not clear whether
the different graft materials and membranes were used
in comparable clinical situations or whether differences
in original defect size may have accounted for some of
the differences in survival rates. In addition, the data
were only evaluated for implant survival and not for im-
plant success. This is due to the fact that in clinical stud-
ies, the success of dental implants is commonly defined
by implant survival. Although different criteria for im-
plant success were suggested in the 1980s and early
1990s [32, 34–37], the success rate addressing pros-
thetic, biological and aesthetic complications was largely
absent from the literature in the 1990s and was newly
established only 5 to 10 years ago. Despite of the
international proposed criteria, a common consensus
could not be reached so far. In addition, Buch et al.
compared the different criteria proposed for implant
success with regard to their clinical value [38]. The au-
thors demonstrated that the proposed criteria led to
very different success rates 6 years after implant inser-
tion (75–89%) and did not allow reliable comparison of
the results with each other. Thus, during control visits
in our practices, only prosthetic complications, but no
other factors essential on reporting implant success
rates were documented. Especially in the anterior max-
illa, the documentation of factors essential for a good
aesthetic outcome with long-term stability would be of
high importance. Another fact is that all inserted im-
plants were intentionally included, irrespective of the
indication, the augmentation materials used and irre-
spective of whether they were already in function or
not. It would be of interest to evaluate the potential
impact of different implantation and augmentation
procedures on early and late implant loss as other au-
thors could show remarkable effect on early and late
implant failure [39, 40].
Due to this, clear conclusions on the advantages of
certain procedures, materials, healing or loading times
are not possible and might be subject to further discus-
sion. According to a retrospective 10-year observation,
most implant failures occurred before loading [41]. In
most of the cases, the clinical cause was unclear, but
17.5% were due to iatrogenic conditions and only 3%
could be attributed to poor bone quality and quantity.
This, together with our own analysis suggests that early
implant loss is related to a learning curve and the sur-
geons’ experience, as we have encountered that early im-
plant loss was halved after approximately every 500
implants.
Nevertheless, our analysis indicates that under the
conditions of daily practice, implants in augmented bone
have survival rates that tend to be even better than im-
plants inserted in native bone.
Conclusions
In this retrospective analysis, more than 10,000 implants
were included followed up to 20.2 years. They were
inserted in a variety of indications either with or without
augmentation procedures. While it was not possible to
draw clear conclusions on the superiority of a certain
augmentation procedure, a graft material or a membrane
as the indication for the different materials and proce-
dures might vary; the data indicated that implant sur-
vival in augmented bone may be slightly better than in
pristine bone. Further well-designed, prospective, rando-
mised, long-term studies are needed to get greater in-
sights into this subject.
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